Tpo mimetics romiplostim and eltrombopag stimulate megakaryocytopoiesis by mechanisms similar to those respondible for hereditary thrombocytosis.In particular, eltrombopag, a nonpeptide Tpo mimetic, binds to MPL in its transmembrane region and directly activates the signal transduction pathway. Thus, chronic eltrombopag administration reminds the constitutive activation of MPL as observed in patients with MPL germline muatations. Since these patients usually develop with aging bone marrow fibrosis, and given that these drugs have to be lifelong administered, concern emerged when it was noticed that some patients with immune thrombocytopenia (ITP) receiving romiplostin developed bone marrow fibrosis.

Teofili, L., Giona, F., Martini, M., Torti, L., Cenci, T., Foa', R., Leone, G., Larocca, L. M., Thrombopoietin receptor activation, thrombopoietin mimetic drugs, and hereditary thrombocytosis: remarks on bone marrow fibrosis, <<Journal of clinical oncology : official journal of the American Society of Clinical Oncology>>, 2010; 28 (19): e317-e317-8. [doi:10.1200/JCO.2010.29.0387] [http://hdl.handle.net/10807/23739]

Thrombopoietin receptor activation, thrombopoietin mimetic drugs, and hereditary thrombocytosis: remarks on bone marrow fibrosis

Teofili, Luciana;Martini, Maurizio;Torti, Lorenza;Cenci, Tonia;Leone, Giuseppe;Larocca, Luigi Maria
2010

Abstract

Tpo mimetics romiplostim and eltrombopag stimulate megakaryocytopoiesis by mechanisms similar to those respondible for hereditary thrombocytosis.In particular, eltrombopag, a nonpeptide Tpo mimetic, binds to MPL in its transmembrane region and directly activates the signal transduction pathway. Thus, chronic eltrombopag administration reminds the constitutive activation of MPL as observed in patients with MPL germline muatations. Since these patients usually develop with aging bone marrow fibrosis, and given that these drugs have to be lifelong administered, concern emerged when it was noticed that some patients with immune thrombocytopenia (ITP) receiving romiplostin developed bone marrow fibrosis.
Inglese
Teofili, L., Giona, F., Martini, M., Torti, L., Cenci, T., Foa', R., Leone, G., Larocca, L. M., Thrombopoietin receptor activation, thrombopoietin mimetic drugs, and hereditary thrombocytosis: remarks on bone marrow fibrosis, <<Journal of clinical oncology : official journal of the American Society of Clinical Oncology>>, 2010; 28 (19): e317-e317-8. [doi:10.1200/JCO.2010.29.0387] [http://hdl.handle.net/10807/23739]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/23739
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact